The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2Council on Pharmacy and Chemistry (American Medical Association)
Science
The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2
Council on Pharmacy and Chemistry (American Medical Association)
Patent medicines
“‘I can speak in very high praise of Secretogen, which I have used in
both tablet form and as the elixir. There is no doubt about its value
in a certain class of intractable indigestion which refuses to be
benefited by any other remedy. On several occasions I have been much
gratified by the definite relief obtained in this class of cases. It
hits the mark also in some types of obstinate constipation--I think
those cases where the trouble is wrapped up in impaired enervation
of the intestine, and where stasis occurs at certain segments of the
canal.’
“Hallion very pertinently points out[108] that it is now accepted that
opotherapy is not substitutive, but homostimulative and he remarks
further that it is well to bear in mind that the so-called active
substances which make the extract efficacious need not necessarily be
the hormones. ‘It may be the elements of tissue structure which may
come to the aid of the injured organ. The hormone should not therefore
be looked on as the only active agent of opotherapy and, while its
action is important, it need not necessarily be preponderant. The
chemical isolation of the hormones is, of course, of interest but may
not be as vital to organotherapy as we have thought.’ ...”
[108] Presse Médicale, 1912, p. 433.
COMMENT BY THE COUNCIL ON PHARMACY AND CHEMISTRY
The G. W. Carnrick Company, which formerly claimed that Secretogen was
efficacious because it contained secretin, now admits this claim to be
unfounded. Notwithstanding, the manufacturers still call their product
Secretogen and make for it practically the same therapeutic claims as
before. They now base these claims on vague “principles of opotherapy”
and on so-called “clinical testimony.” The burden of proof rests on
them to show that these old claims, already discredited but put forth
again on new grounds, are justified. Have they done so?
The “clinical te stimony” is not convincing. So much of it as is
definite enough to permit of criticism has already been dealt with. The
remainder consists of mere assertions; it is not through reliance on
such evidence that the Council can discharge its trust. On this side of
the question there is nothing new to be said--reassertion of a refuted
argument does not constitute fresh proof.
Nor is the case better on the experimental side. The statements of
Hallion, Enriquez, Zuelzer and others[109] as to the existence of a
“peristaltic hormone” not only have failed of confirmation, but also
have been positively discredited. With regard to Draper’s work, which
dealt with acute intestinal obstruction, it is difficult to see what is
its relevance to the present issue, particularly since Draper’s results
were obtained with a product derived from the mucosa of the jejunum
and ileum and _not with an extract of the duodenum_ such as Secretogen
purports to be.
[109] Cf. interal. Schagindweit, E.: Experimentelle Versuche mit
Hormonal, Arch. Internat. de Pharmacod., 1913, p. 77.
Public-domain text, read in full here on John Shaqi.
Reviews
Reviews
No reviews yet
Be the first to share your thoughts on this work.
Elsewhere in the archive
Join the Discussion
Join the discussion
Sign in to leave a comment or review.
Sign InorCreate an account